全文获取类型
收费全文 | 37615篇 |
免费 | 3424篇 |
国内免费 | 866篇 |
专业分类
耳鼻咽喉 | 464篇 |
儿科学 | 1182篇 |
妇产科学 | 510篇 |
基础医学 | 2944篇 |
口腔科学 | 124篇 |
临床医学 | 5979篇 |
内科学 | 11056篇 |
皮肤病学 | 172篇 |
神经病学 | 2139篇 |
特种医学 | 1677篇 |
外国民族医学 | 2篇 |
外科学 | 4136篇 |
综合类 | 4432篇 |
现状与发展 | 2篇 |
一般理论 | 6篇 |
预防医学 | 2098篇 |
眼科学 | 97篇 |
药学 | 2733篇 |
24篇 | |
中国医学 | 807篇 |
肿瘤学 | 1321篇 |
出版年
2024年 | 24篇 |
2023年 | 772篇 |
2022年 | 864篇 |
2021年 | 1643篇 |
2020年 | 1829篇 |
2019年 | 1746篇 |
2018年 | 1614篇 |
2017年 | 1347篇 |
2016年 | 1226篇 |
2015年 | 1389篇 |
2014年 | 2437篇 |
2013年 | 2734篇 |
2012年 | 1824篇 |
2011年 | 2017篇 |
2010年 | 1585篇 |
2009年 | 1629篇 |
2008年 | 1689篇 |
2007年 | 1616篇 |
2006年 | 1513篇 |
2005年 | 1360篇 |
2004年 | 1136篇 |
2003年 | 1041篇 |
2002年 | 874篇 |
2001年 | 828篇 |
2000年 | 645篇 |
1999年 | 654篇 |
1998年 | 557篇 |
1997年 | 551篇 |
1996年 | 439篇 |
1995年 | 507篇 |
1994年 | 459篇 |
1993年 | 374篇 |
1992年 | 375篇 |
1991年 | 341篇 |
1990年 | 291篇 |
1989年 | 226篇 |
1988年 | 222篇 |
1987年 | 197篇 |
1986年 | 167篇 |
1985年 | 233篇 |
1984年 | 200篇 |
1983年 | 133篇 |
1982年 | 97篇 |
1981年 | 115篇 |
1980年 | 85篇 |
1979年 | 62篇 |
1978年 | 57篇 |
1977年 | 55篇 |
1976年 | 43篇 |
1975年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
《The Journal for Nurse Practitioners》2019,15(1):139-145.e1
This study explored the lived experiences of family members who were referred to a cardiogenetics clinic after the loss of a family member to sudden cardiac death. Participants revealed many health concerns and emotions, including disappointment, guilt, ambivalence, blame, and fear of loss. Understanding these findings and their potential effect on the family members may provide nurse practitioners with the ability to improve the quality of care that is offered to family members after sudden cardiac death and further the knowledge for genetic testing and disease management. 相似文献
45.
Joakim Nordanstig Odd Bech-Hanssen Per Skoog Lennart Jivegård 《Scandinavian cardiovascular journal : SCJ》2019,53(3):153-161
Objective. Skeletal muscle perfusion during walking relies on complex interactions between cardiac activity and vascular control mechanisms, why cardiac dysfunction may contribute to intermittent claudication (IC) symptoms. The study aims were to describe cardiac function at rest and during stress in consecutive IC patients, to explore the relations between cardiac function parameters and treadmill performance, and to test the hypothesis that clinically silent myocardial ischemia during stress may contribute to IC limb symptomatology. Design. Patients with mild to severe IC (n?=?111, mean age 67 y, 52% females, mean treadmill distance 195 m) underwent standard echocardiography, dobutamine stress echocardiography (SE) and treadmill testing. The patient cohort was separated in two groups based on treadmill performance (HIGH and LOW performance). Results. Ten patients (9%) had regional wall motion abnormalities of which three had left ventricular ejection fraction <50% at standard echocardiography. A majority had lower than expected systolic- and diastolic ventricular volumes. LOW performers had smaller diastolic left ventricular volumes and lower global peak systolic velocity during dobutamine stress. No patient demonstrated significant cardiac dysfunction during dobutamine provocation that was not also evident at standard echocardiography. Conclusions. Most IC patients were without signs of ischemic heart disease or cardiac failure. The majority had small left ventricular volumes. The hypothesis that clinically silent myocardial ischemia impairing left ventricular function during stress may contribute to IC limb symptomatology was not supported.Trial registration: ClinicalTrials.gov identifier: NCT01219842. 相似文献
46.
47.
Wilson Mathias Jeane M. Tsutsui Bruno G. Tavares Agostina M. Fava Miguel O.D. Aguiar Bruno C. Borges Mucio T. Oliveira Alexandre Soeiro Jose C. Nicolau Henrique B. Ribeiro Hsu Po Chiang João C.N. Sbano Abdulrahman Morad Andrew Goldsweig Carlos E. Rochitte Bernardo B.C. Lopes José A.F. Ramirez Roberto Kalil Filho Thomas R. Porter 《Journal of the American College of Cardiology》2019,73(22):2832-2842
BackgroundPreclinical studies have demonstrated that high mechanical index (MI) impulses from a diagnostic ultrasound transducer during an intravenous microbubble infusion (sonothrombolysis) can restore epicardial and microvascular flow in acute ST-segment elevation myocardial infarction (STEMI).ObjectivesThis study tested the clinical effectiveness of sonothrombolysis in patients with STEMI.MethodsPatients with their first STEMI were prospectively randomized to either diagnostic ultrasound–guided high MI impulses during an intravenous Definity (Lantheus Medical Imaging, North Billerica, Massachusetts) infusion before, and following, emergent percutaneous coronary intervention (PCI), or to a control group that received PCI only (n = 50 in each group). A reference first STEMI group (n = 203) who arrived outside the randomization window was also analyzed. Angiographic recanalization before PCI, ST-segment resolution, infarct size by magnetic resonance imaging, and systolic function (LVEF) at 6 months were compared.ResultsST-segment resolution occurred in 16 (32%) high MI PCI versus 2 (4%) PCI-only patients before PCI, and angiographic recanalization was 48% in high MI/PCI versus 20% in PCI only and 21% in the reference group (p < 0.001). Infarct size was reduced (29 ± 22 g high MI/PCI vs. 40 ± 20 g PCI only; p = 0.026). LVEF was not different between groups before treatment (44 ± 11% vs. 43 ± 10%), but increased immediately after PCI in the high MI/PCI group (p = 0.03), and remained higher at 6 months (p = 0.015). Need for implantable defibrillator (LVEF ≤30%) was reduced in the high MI/PCI group (5% vs. 18% PCI only; p = 0.045).ConclusionsSonothrombolysis added to PCI improves recanalization rates and reduces infarct size, resulting in sustained improvements in systolic function after STEMI. (Therapeutic Use of Ultrasound in Acute Coronary Artery Disease; NCT02410330). 相似文献
48.
49.
50.
目的 通过阿霉素(Dox)复制大鼠慢性心力衰竭(CHF)模型,观察Liguzinediol对CHF大鼠心功能的影响。方法 通过血流动力学观察Liguzinediol对Dox(腹腔注射,2 mg/kg)诱导的CHF大鼠左心室内压最大上升/下降速率(±dp/dtmax)、左心室内压(LVSP)、动脉收缩压(ASP)、动脉舒张压(ADP)和心率(HR)的变化;观察Liguzinediol对血清一氧化氮(NO)、一氧化氮合成酶(NOS)、超氧化物歧化酶(SOD)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)以及血浆中丙二醛(MDA)的影响。结果 Liguzinediol能增加LVSP、+dp/dtmax、ASP、ADP、AP、HR,降低-dp/dtmax(P<0.05~0.01);降低NO、iNOS以及MDA的浓度,同时增强了SOD的活性(P<0.05~0.01);抑制IL-6和TNF-α的生成(P<0.05~0.01)。结论 Liguzinediol可明显改善Dox诱导的CHF大鼠血流动力学指标,减少模型大鼠炎症因子的释放以及抑制氧自由基的生成。 相似文献